PHARMACY

The FDA approval of Selarsdi 130 mg/26 ml in a single-dose vial for intravenous infusion expands the label to include treatment of adults with Crohn’s disease and ulcerative colitis.

Tim Ducharme, vice president of Immunization Growth and Strategy at CVS Health, discusses the company’s vaccination business and its offerings for the respiratory virus season.

The terms of the agreement remain confidential.

Impli’s goal is to advance women’s health and deliver the first real-time hormone monitoring device.

Pyridostigmine bromide ER is a once-daily soman nerve agent pretreatment pyridostigmine product for the U.S. armed services and U.S. allies.

The licensing agreement includes exclusive rights for multiple markets, including Europe and the United States.

This year’s Q4 report reflects tocilizumab’s market share and wholesale acquisition cost trend analysis after biosimilars launched in Q2.

This month, DSN is celebrating pharmacists who go above and beyond their everyday roles.